Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
Home U.S. FDA Drug Regulations › U.S. FDA Drug Labeling Requirements

U.S. FDA Drug Labeling Requirements


U.S. FDA Drug Labeling Regulations Can Be Complicated

Registrar Corp's team of Regulatory Advisors can provide a Free Assessment of how these regulations apply to your particular product. Simply click below to provide information about your products.

Learn if these regulations apply to you >>


The U.S. Federal Food, Drug and Cosmetic Act (FFDCA) defines 'labeling' as all labels and other written, printed, or graphic matter upon any article or any of its containers or wrappers, or accompanying such article. The term 'accompanying' is interpreted liberally to mean more than physical association with the product. It extends to posters, tags, pamphlets, circulars, booklets, brochures, instructions, websites, etc.

Registrar Corp's Drug Labeling and Ingredient Review service helps companies determine their drug's likely classification and compliance with applicable labeling requirements. Registrar Corp cross references your labeling against thousands of pages within the Code of Federal Regulations as well as the Federal Register, CDER's Listing of OTC Active Ingredients, Rulemaking History for Nonpresciption Products, Guidance Documents and Warning Letters issued by U.S. FDA. Registrar Corp's label review service provides:

  • A detailed report (typically 30-40 pages) prepared by our team of regulatory specialists who scrutinize each element of your labeling (including inner packaging, outer packaging, website, etc.).
  • A print-ready graphic file of your revised label which incorporates our recommended changes.
  • A generous revision policy providing additional reports and revisions for the same label within 90 days at no extra cost.
Drug Label Example of Before and After Registrar Corp Labeling and Ingredient Review

Learn if these regulations apply to you >>




 
U.S. FDA Regulations:

U.S. FDA Drug Labeling: 21 C.F.R. Part 201 Subparts A and C


Fee:

Drug Labeling Review: US$1495/product.

Discounts are available for multiple products.









Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco